Measles Virus Antibodies IgG, Quantitative (Serum)
The study is aimed at quantitative determination of IgG class antibodies to the measles virus in serum.
Used for assessing immunity level after past disease or vaccination.
Allows determination of whether the immunity is protective and whether the antibody level is sufficient for disease prevention.
Prescribed for resolving the issue of revaccination necessity.
Applied when planning pregnancy, before vaccination, and as part of epidemiological and preventive examinations.
Used for assessing immune status in healthcare workers and other high-risk groups.
What the test assesses:
– Quantitative concentration of IgG antibodies to the measles virus.
– Degree of specific immunity intensity to the measles virus.
– Level of serological body protection.
Biomaterial: Venous blood (serum)
– Submit fasting.
– Drinking still water is allowed.
– It is advisable to avoid intense physical exertion the day before the examination.
Medications:
– Medication intake usually does not affect the result.
– It is recommended to submit the test before vaccination or no earlier than 4-6 weeks after it.
– When administering immunoglobulins, be sure to inform the doctor, as this may affect antibody levels.
Recommended for testing:
– During preventive examinations and assessment of post-vaccination immunity.
– For determining immune status and interpreting results upon contact with a measles patient.
– When planning pregnancy to exclude primary infection risk.
– When examining contact persons during measles outbreaks.
– For healthcare workers, educational institution staff, and other occupational risk groups.
– Protective IgG level: indicates formed immunity after vaccination or past disease.
– Low or borderline IgG level: insufficient immunity, revaccination is recommended.
– Absence of IgG: no immunity present, high infection risk upon contact with the measles virus.
Important — threshold values depend on the test system used and are indicated on the result form.
